Table 1.
Characteristics of included studies.
| Study | Country | Design | Sample size, n | Ta/Cb, n | Intervention | Control | Time interval | Outcome measures and their values (T/C), mean (SD) |
| Borjalilu et al [25] | Iran | Quasi-experimental study | 48 | 28/20 | Applied the “Aramgar” stress management app | Face-to-face therapy only | 6 weeks |
|
| Champion et al [37] | United States | RCTc | 74 | 38/36 | The self-guided mindfulness meditation app “Headspace” | Waitlist control | 30 days |
|
| Huberty et al [23] | United States | RCT | 88 | 41/47 | The “Calm” smartphone app | Waitlist control | 8 weeks |
|
| Lee and Jung [38] | Canada | RCT | 163 | 77/86 | The “DeStressify” app | Waitlist control | 8 weeks |
|
| Noone and Hogan [39] | Ireland | RCT | 91 | 43/48 | The “Headspace” app | Sham meditation group | 6 weeks |
|
| Orosa-Duarte et al [26] | Spain | RCT | 61 | 31/30 | The “REM Volver a casa” (Mindfulness-Based Emotion Regulation. Going Home”) app | Did not receive any intervention | 8 weeks |
|
| Ponzo et al [40] | United Kingdom | RCT | 116 | 55/61 | The “BioBase” app | Waitlist control | 4 weeks |
|
| Raevuori et al [27] | Finland | RCT | 124 | 63/61 | The Meru Health Program via smartphone | Treatment as usual | 8 weeks |
|
| Harrer et al [22] | Germany | RCT | 105 | 40/65 | An app-based intervention with feedback on demand (StudiCare Stress) | Waitlist control | 7 weeks |
|
| Yang et al [24] | United States | RCT | 88 | 45/43 | The “Headspace” app | Waitlist control | 30 days |
|
aT: test group.
bC: control group.
cRCT: randomized controlled trial.